Join
Live feed
·
PRReleasevia Quantisnow
Achieve Life Sciences Inc. logo

Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial

ByQuantisnow·Wall Street's wire, on your screen.
ACHV· Achieve Life Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACHV (Achieve Life Sciences Inc.) and more on Quantisnow.